Failure of a gonadotropin-releasing hormone analogue to lower serum testosterone in patients with prostate cancer-Reference-Cited by-同舟云学术

Failure of a gonadotropin-releasing hormone analogue to lower serum testosterone in patients with prostate cancer

Published:2002-02 Issue:2 Volume:59 Page:296
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Matsuda Tadashi,Hiura Yoshihito,Oguchi Naoki,Muguruma Koei,Murota Takashi,Kawakita Mutsushi

Publisher

Elsevier BV

Subject

Urology

Reference6 articles.

1. Idiopathic resistance to luteinizing hormone-releasing hormone analogue in a patient with prostatic carcinoma;Jorion;J Urol,1992

2. Resistance to gonadotropin-releasing hormone agonist in a patient with metastatic prostate cancer;Krongrad;South Med J,1997

3. Gonadotropin-releasing hormone agonist failure in a man with prostate cancer;Smith;J Urol,2001

4. Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone;Kerle;BMJ,1984

5. Clinical effect of slow release (depot) formulation of the LH-RH analogue ICI 118630 (Zoladex) in patients with prostatic carcinoma;Usami;Acta Urol Jpn,1987

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer;Anti-Cancer Drugs;2020-08-17

2. Evidence-based medicine: comparative analysis of luteinizing hormone-releasing hormone analogues in combination with external beam radiation and surgery in the treatment of carcinoma of the prostate;BJU International;2010-11-15

3. ¿Se ha de asumir el efecto de clase farmacológica entre los diferentes análogos de la hormona liberadora de la hormona luteinizante usados en el tratamiento del carcinoma de próstata?;Actas Urológicas Españolas;2010-10

4. Does the pharmacological class effect between the different luteinizing hormone releasing hormone analogues used in the treatment of prostate cancer have to be assumed?;Actas Urológicas Españolas (English Edition);2010-01

5. Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer;BJU International;2008-05